Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie lannelongue Le Plessis Robinson - France

16
Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie lannelongue Le Plessis Robinson - France Thymic changes in Myasthenia Gravis: Involvement of chemokines in thymic hyperplasia associated with an inflammatory environment International conference on Myasthenia December 1-2, 2009 - Paris - France

description

Thymic changes in Myasthenia Gravis:. Involvement of chemokines in thymic hyperplasia associated with an inflammatory environment. Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie lannelongue Le Plessis Robinson - France. International conference on Myasthenia - PowerPoint PPT Presentation

Transcript of Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie lannelongue Le Plessis Robinson - France

Page 1: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Rozen Le PanseCNRS UMR 8162

Centre Chirurgical Marie lannelongueLe Plessis Robinson - France

Thymic changes in Myasthenia Gravis:Involvement of chemokines in thymic hyperplasia

associated with an inflammatory environment

International conference on MyastheniaDecember 1-2, 2009 - Paris - France

Page 2: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Implication of the thymus in MG

Cellules épithéliales corticales

Cellules épithéliales médullaires

Thymocytes

Cellules épithéliales corticales

Cellules épithéliales médullaires

Thymocytes

AChR+ Myasthenia Gravis (MG) AChR expression (Wakkach et al., 1996) Anti-AChR autoreactive T cells (Melms et al., 1988)B cells producing anti-AChR antibodies (Leprince et al., 1990

AChR

Thymus

Muscle

!

Page 3: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Méraouna et al., Blood 2006

Ectopic germinal centers (GCs)

Germinal centers (CD21 labeling)Epithelial cells (keratin labeling)

Adult control MG + corticoïdsMG

Thymic hyperplasia in AChR+ MG

% o

f CD

21+

area

s

0.01

0.1

1

10

p<0.003p<0.001

MG + Cortico MG Controls

Page 4: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Neoangiogenesis is associated with thymic hyperplasia

Adult

MH

HEVs

KeratinGCs

Number of HEVs

0

50

100

150

200

p=0.0714p=0.0357

HEV

s/th

ymic

sec

tion

MG

HEVsGCs

Ectopic high endothelial venules (HEVs)

Berrih-Aknin et al., Ann. of Neurol. 2009

Lymphangiogenesis

Adults MH0

50

100

150

200

250

300

p<0.05

Adults MH0

25

50

75

100

125

150

175

p<0.01

VEG

FR3

mR

NA

(AU

)

PRO

X1 m

RN

A (A

U)

Adult control

HEVs

StromaGCs

Page 5: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Role of chemokine in thymic hyperplasia

Expression of chemokines involved in GC formation

Thymic transcriptome analysis revealed a chemotactic signature in the hyperplastic thymus of MG patients.

Chemotactic assays

Le Panse et al., J. Immunol 2006

CXCL13 CCL21 BB Ad MH Cortico

0

2

4

6

8

10 p<0.001 p<0.001

CXC

L13

(ng/

mg

of p

rote

in)

BB Ad MH Cortico0

1

2

3

4p<0.001 p<0.001

CC

L21

(ng/

mg

of p

rote

in)

Ad ML MH SN-100

0

100

200

300

400

500

p<0.05

p<0.05

Cel

l mig

ratio

n(fl

uore

scen

ce m

ean)

ELISA

Page 6: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Analysis of CXCL13 overexpression in MG

Méraouna et al., Blood 2006

CXCL13 overexpression by thymic epithelial cells

Ad BB MG

100

200

Ad BB MG

100

200

CXC

L13

mR

NA

(AU

)

Q-PCR on thymicepithelial cells

Laser-capturemicrodissection

Q-PCRon CXCL13

Page 7: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Generation of transgenic mice for CXCL13

WT1 WT2 WT3 Tg-A1 Tg-A2 Tg-B10

50

100

150

CXC

L13

mR

NA

norm

aliz

ed o

n G

APD

H (A

U)

Increased expression of CXCL13 and B-cell recruitment

Weiss et al., in progress

polyAKeratin 5 promoter CXCL13

Kpn I

5,2 kb EGFP0,8 kb 1,2 kb

Not I Not I0,5 kb

Promoteur K5 Intron β-Globine

Poly-A5,2 kb EGFP

0,8 kbEGFP0,8 kb 1,2 kb

Not I Not I0,5 kb

Promoteur K5 Intron β-Globine

Poly-A

Kpn I

Kpn IKpn I

5,2 kb EGFP0,8 kb 1,2 kb

Not I Not I0,5 kb

Promoteur K5 Intron β-Globine

Poly-A5,2 kb EGFP

0,8 kbEGFP0,8 kb 1,2 kb

Not I Not I0,5 kb

Promoteur K5 Intron β-Globine

Poly-A

Kpn I

Kpn IKpn I

5,2 kb EGFP0,8 kb 1,2 kb

Not I Not I0,5 kb

Promoteur K5 Intron β-Globine

Poly-A5,2 kb EGFP

0,8 kbEGFP0,8 kb 1,2 kb

Not I Not I0,5 kb

Promoteur K5 Intron β-Globine

Poly-A

Kpn IKpn I

Kpn I

Not1 Not1

pEYFP-1

Heterozygous…

B220Keratin

Q-PCR on CXCL13 Immunofluorescence

Page 8: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Analysis of CCL21 overexpression in MG

VEGFR3CCL21

0 0.5 5 50 125 250 5000

100

200

300350550750950

1150 T cellsB cells

p<0.0001ng/ml

0 100 200 300 400 500 600 700 800

CD27-IgD+

CD27-IgD-

% of migration towards CCL21compared to passive migration (100%)

Naive B cells

DifferentiatedB cells

p=0.

0317

CD

19+

B c

ells0

500

10005000

7500

10000

WS

_

LEC

CCL2

1+

vess

els

HUVEC

WS

_

CCL2

1+

vess

els

Non-MGadults

MG (MH)patients

PROX1

mRNA e

xpre

ssio

n (A

U)

norm

alised

with

28S

p=0.076 p=0.05

0

500

10005000

7500

10000

D6 m

RNA e

xpre

ssio

n (A

U)

norm

alised

with

28S

Non-MGadults

MG (MH)patients

WS

_

LEC

CCL2

1+

vess

els

HUVEC

WS

_

CCL2

1+

vess

els

p=0.076

D6 m

RNA

(AU)

WS

_

LEC

CC

L21

+ve

ssel

s

HU

VE

C

WS

_

CCL2

1+

vess

els

PRO

X1 m

RNA

(AU)

0

500

10005000

7500

10000

WS

_

LEC

CCL2

1+

vess

els

HUVEC

WS

_

CCL2

1+

vess

els

Non-MGadults

MG (MH)patients

PROX1 mRNA e

xpress

ion (A

U)

norm

alised

with

28S

p=0.076 p=0.05

0

500

10005000

7500

10000

D6 mRNA e

xpress

ion (A

U)

norm

alised

with

28S

Non-MGadults

MG (MH)patients

WS

_

LEC

CCL2

1+

vess

els

HUVEC

WS

_

CCL2

1+

vess

els

p=0.076

% o

f cel

l mig

ratio

nCCL21 overexpression by lymphatic vessels

HEVsCCL21

Berrih-Aknin et al., Ann. of Neurol. 2009

Immunofluorescence Transwell assaysQ-PCR for PROX1 and D6

Page 9: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Julia Weiss : Poster 16

Expression of SDF1 on thymic HEVs

Search for chemokines on HEVs

HEVsSDF1

MG

Transcytosis ?

Immunofluorescence

Page 10: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Roles of chemokines in thymic hyperplasia

Signals triggering these thymic dysregulations ?

Thymus

Epithelial cells

CXCL13

Lymphaticendothelial cells

CCL21

GC

T

TnDC

BB

BB

BB

B

B

B

B

BB

BFDC

B

T

T

T

BT

B

Tn

Tn

TT

TT

TnTn

BB

BB

BB

B

B

B

B

BB

FDC

B

BB

BB

BB

B

B

B

BBBB

BBB

BBBB

BB

BB

BB

BB

BBBB

B

BB

T

T

BTT

B

TnTn

HEV

SDF1-α

CXCL10 (Feferman et al., 2003)

CXCL9-CXCL11 (Transcriptomic analysis)

RANTES (Colombarra et al., 2005)

Peripheral cell recruitment

Page 11: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Microarray analysis revealed a role for IFN-I in MG

Adults MH Cortico0.0

0.5

1.0

1.5

2.0 p=0.007 p=0.008

Mic

roar

ray

ratio

s of

type

Iin

terf

eron

indu

ced

gene

s

Ad MG0

20

40

60

80

100p<0.05

-IF

N (p

g/m

g of

pro

tein

)

Ad MG0

1

2

3

4

-IF

N s

ubty

pes

(pg/

mg

of p

rote

in)

Ad MG0

50

100

150

200p<0.01

IFN-

m

RNA

expr

essi

on

Ad MG0

200

400

600

IFN-

2

mRN

A ex

pres

sion

Increased expression of IFN- in MG thymuses

Cufi et al., in progress

-IFN

-IFN

Microarray data Q-PCR and ELISA

Page 12: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Roles of IFN-I on chemokine expression

IFN-I IFN-IIU/ml

CCL21

Lymphatic endothelial cells(Dermal LECs)

Perrine Cufi : Poster 14

IFN-I induces the expression of :• CXCL13 and CCL21• -AChR

Thymic epithelial cells

IFN-I IFN-IIU/ml

CXCL13

IFN-I

-AChR

Page 13: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Potential involvement of viral infection in MG

Cufi et al., in progress

Specific effect of Poly(I:C)

Selective effect on the -AChR subunit

0

400

800

1200

0 25 50 100

AC

hR s

ubun

it m

RN

A (A

U)

Poly(I:C) (µg/ml)

0

600

1200

1800

100

p<0.0001

p<0.002

Auto

antig

en m

RN

A ex

pres

sion

(AU

)

-AChR-AChr-AChR

-AChR-AChr-AChR

0

1000

2000

3000p<0.001

-A

ChR

mR

NA

(AU

)

TLR1/2

TLR3

TLR4 TLR6/2 TLR7 TLR7/8 TLR9TLR5

Page 14: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

In vivo confirmation of Poly(I:C) effects on -AChR

Poly(I:C) Control

-AChR -AChR

Cufi et al., in progress

Thymic upregulation of -AChR expression by Poly(I:C)

Control Poly(I:C)0

50

100

150

200

250 p<0.009

-A

ChR

mR

NA

(AU

)

Control Poly(I:C)0

50

100

150

200

-A

CH

R m

RN

A (A

U)

Q-PCR on AChR subunits

Page 15: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Could a viral infection, under particular conditions, trigger thymic changes involved in MG?

Conclusion

Thymic Hyperplasia

MDA5

RIG-IPKR

TLR3

dsRNA/Poly(I:C)

Thymic Epithelial Cells

Endosome

Nucleus IFN-β α-ACHR

IFNAR1

IFNAR2

α-ACHR

CCL21

Lymphatic endothelial cells

CXCL13

Page 16: Rozen Le Panse CNRS UMR 8162 Centre Chirurgical Marie  lannelongue Le Plessis Robinson - France

Julia Weiss

Perrine Cufi

Nathalie Ruhlman

Géraldine Cizeron-Clairac

Jacky Bismuth

Frédérique Truffault

Amel Méraouna

Sonia Berrih-Aknin

Nicole Kerlero de Rosbo

WEIZMANN INSTITUTE

Idit ShacharFrida Lantner

UMR 8162

Acknowledgements